View Rule
View EO 12866 Meetings | Printer-Friendly Version Download RIN Data in XML |
HHS/FDA | RIN: 0910-AG48 | Publication ID: Fall 2014 |
Title: Human Subject Protection; Acceptance of Data From Clinical Investigations for Medical Devices | |
Abstract: This rule will amend FDA's regulations on acceptance of data from clinical investigations for medical devices to require that clinical investigations conducted outside the United States in support of a premarket approval application, humanitarian device exemption application, an investigational device exemption application, or a premarket notification submission be conducted in accordance with good clinical practice. | |
Agency: Department of Health and Human Services(HHS) | Priority: Other Significant |
RIN Status: Previously published in the Unified Agenda | Agenda Stage of Rulemaking: Final Rule Stage |
Major: No | Unfunded Mandates: No |
CFR Citation: 21 CFR 807 21 CFR 812 21 CFR 814 | |
Legal Authority: 21 USC 321 21 USC 331 21 USC 351 21 USC 352 21 USC 360 21 USC 360c 21 USC 360e 21 USC 360i 21 USC 360j 21 USC 371 21 USC 374 21 USC 381 21 USC 393 42 USC 264 42 USC 271 ... |
Legal Deadline:
None |
||||||||||||
Timetable:
|
Regulatory Flexibility Analysis Required: Yes | Government Levels Affected: None |
Small Entities Affected: Businesses | Federalism: No |
Included in the Regulatory Plan: No | |
International Impacts: This regulatory action will be likely to have international trade and investment effects, or otherwise be of international interest. | |
RIN Data Printed in the FR: Yes | |
Agency Contact: Aaliyah K. Eaves Policy Advisor, Office of the Director Department of Health and Human Services Food and Drug Administration Center for Devices and Radiological Health, WO 66, Room 5422, 10903 New Hampshire Avenue, Silver Spring, MD 20993 Phone:301 796-2948 Fax:301 847-8120 Email: aaliyah.eaves-leanos@fda.hhs.gov |